CS
TTPH

Credit Suisse’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Credit Suisse’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-657
Closed -$7K – 4333
2019
Q2 		$7K Buy
657
+5
+0.8% +$92 ﹤0.01% 4064
2019
Q1 		$18K Buy
+652
New +$16.6K ﹤0.01% 3945
2018
Q3 		– Sell
-788
Closed -$57K – 4102
2018
Q2 		$57K Sell
788
-363
-32% -$25.6K ﹤0.01% 3894
2018
Q1 		$70K Sell
1,151
-154
-12% -$13.5K ﹤0.01% 3850
2017
Q4 		$164K Sell
1,305
-528
-29% -$67.6K ﹤0.01% 3779
2017
Q3 		$251K Buy
+1,833
New +$245K ﹤0.01% 3828
2017
Q2 		– Sell
-553
Closed -$102K – 4022
2017
Q1 		$102K Sell
553
-613
-53% -$68.7K ﹤0.01% 3694
2016
Q4 		$93K Sell
1,166
-1,092
-48% -$86.4K ﹤0.01% 3960
2016
Q3 		$173K Sell
2,258
-148
-6% -$11.9K ﹤0.01% 3847
2016
Q2 		$208K Sell
2,406
-518
-18% -$47.5K ﹤0.01% 3856
2016
Q1 		$271K Sell
2,924
-765
-21% -$76.4K ﹤0.01% 3559
2015
Q4 		$741K Buy
3,689
+1,441
+64% +$288K ﹤0.01% 3071
2015
Q3 		$336K Sell
2,248
-713
-24% -$523K ﹤0.01% 3651
2015
Q2 		$2.81M Buy
2,961
+1,406
+90% +$1.15M ﹤0.01% 2268
2015
Q1 		$1.14M Buy
1,555
+651
+72% +$489K ﹤0.01% 2864
2014
Q4 		$718K Buy
+904
New +$487K ﹤0.01% 3426
2014
Q2 		– Sell
-1,397
Closed -$304K – 4872
2014
Q1 		$304K Buy
1,397
+568
+69% +$158K ﹤0.01% 4090
2013
Q4 		$224K Buy
+829
New +$198K ﹤0.01% 4271
2013
Q3 		– Sell
-3,471
Closed -$488K – 4428
2013
Q2 		$488K Buy
+3,471
New +$550K ﹤0.01% 3321

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Credit Suisse's TTPH Position: Q3 2019 in Review

Credit Suisse sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 657 shares — an estimated $7K sold.

Credit Suisse first reported a position in TTPH in Q2 2013 and held it in 19 quarters. The position peaked at $2.81M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Credit Suisse reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Credit Suisse sold 657 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $7K.
  • Credit Suisse first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
  • Credit Suisse's Tetraphase Pharmaceuticals, Inc. position peaked at $2.81M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.